AstraZeneca CEO warns Western pharmaceutical sector risks losing innovation edge to China

AstraZeneca CEO Pascal Soriot has urged Western drugmakers to accelerate innovation cycles to match the pace of Chinese competitors, citing the decline of the Western automotive industry as a cautionary precedent. The company is balancing competitive concerns with strategic collaborations to bring Chinese-developed drugs to global markets.